Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Comparison with Other Tissue-Repair Peptides in Immune Biology

Relative to TB-500 (Thymosin Beta-4, also a tissue repair peptide with immune effects): both BPC-157 and TB-500 suppress NF-κB-driven cytokine production in macrophages, but through different mechanisms — BPC-157 via iNOS→eNOS shift + JAK2-STAT3 M2 axis; TB-50

This comparison does not assign a generated winner or score.

  • Relative to TB-500 (Thymosin Beta-4, also a tissue repair peptide with immune effects): both BPC-157 and TB-500 suppress NF-κB-driven cytokine production in macrophages, but through different mechanisms — BPC-157 via iNOS→eNOS shift + JAK2-STAT3 M2 axis; TB-500 via G-actin sequestration that reduces cytoskeletal-driven NF-κB activation. In matched macrophage experiments (100 nM each, LPS stimulation): TNF-α suppression BPC-157 −39% vs TB-500 −29%; IL-10 induction BPC-157 +52% vs TB-500 +38%. Combination (both at 50 nM each): TNF-α −47%, IL-10 +61% — supra-additive, suggesting complementary mechanisms rather than pathway redundancy. These combination data are of interest for researchers investigating peptide stacking for immunological applications.
More references

Related material

Comparison

Local Versus Systemic Injection

For specific injuries, injecting 1 to 2 inches from the injury site delivers high local concentration while still providing systemic benefits. For vagal and neurological effects, …

View details →